Genetics of Symptomatology and Treatment Response in Psychotic Major Depression
NCT00691535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-06-19
Summary
We hope to learn more about the biology of psychiatric illness with the hope of improving the diagnosis and treatment of such psychiatric conditions as major depression.
Conditions
- Psychotic Disorders
- Depressive Disorder
- Depressive Disorder, Major
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Alan F Schatzberg, MD · Stanford University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-10-31
- Primary Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Utility of Pharmacogenomics of Psychotropic Medications
NCT03907124 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
NCT01075373 ·Status: UNKNOWN
-
The BC Psychosis Program Biobank and Database for Genetic Polymorphisms and Their Associations With Psychosis Disorder
NCT02322918 ·Status: UNKNOWN
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
NCT02205437 ·Status: UNKNOWN
-
Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia
NCT01555697 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enhancing the Prospective Prediction of Psychosis
NCT00291200 ·Status: COMPLETED
-
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
NCT02566057 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in First Episode Schizophrenia
NCT02033382 ·Status: COMPLETED
-
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
NCT00701753 ·Status: TERMINATED
-
Prospective Studies of the Pathogenesis of Schizophrenia
NCT00877552 ·Status: COMPLETED
-
Developing Clinical Tools to Communicate Genetic Risk for Individuals Who Are Clinical High Risk for Psychosis
NCT04325568 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia
NCT01036568 ·Status: COMPLETED
-
Screening for Childhood-Onset Psychotic Disorders
NCT00049738 ·Status: TERMINATED
-
Familial Schizophrenia and Spectrum Personality Disorders
NCT00666146 ·Status: COMPLETED
-
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
NCT03790085 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Latent Structure of Multi-level Assessments and Predictors of Outcomes in Psychiatric Disorders
NCT02450240 ·Status: COMPLETED
-
Study of Pharmacotherapy of Psychotic Depression
NCT00056472 ·Status: COMPLETED ·Phase: PHASE3
-
Cerebellar Modulation of Cognition in Psychosis
NCT06107764 ·Status: RECRUITING ·Phase: NA
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
NCT00207064 ·Status: COMPLETED ·Phase: NA
-
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
NCT03442101 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?
NCT05007314 ·Status: COMPLETED ·Phase: NA